These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 8794618

  • 1. [Treatment of tuberculosis].
    Dautzenberg B.
    Rev Prat; 1996 Jun 01; 46(11):1350-5. PubMed ID: 8794618
    [Abstract] [Full Text] [Related]

  • 2. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 01; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 3. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
    Reichlin S, Frei R, Reusser P.
    Schweiz Med Wochenschr; 1998 Feb 14; 128(7):264-7. PubMed ID: 9540152
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of tuberculosis].
    Eier A, Grass S.
    Wien Med Wochenschr; 1994 Feb 14; 144(8-9):186-8. PubMed ID: 7941607
    [Abstract] [Full Text] [Related]

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 14; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 14; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 7. [Antitubercular chemotherapy].
    Jouveshomme S, Dautzenberg B.
    Rev Mal Respir; 1997 Dec 14; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [Abstract] [Full Text] [Related]

  • 8. New drugs for tuberculosis.
    Grassi C, Peona V.
    Eur Respir J Suppl; 1995 Sep 14; 20():714s-718s. PubMed ID: 8590571
    [Abstract] [Full Text] [Related]

  • 9. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec 14; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 10. [Therapy of tuberculosis in the adult].
    Schrappe M, Wassermann K, Kroegel C.
    Med Klin (Munich); 1995 Apr 15; 90(4):229-30. PubMed ID: 7776936
    [No Abstract] [Full Text] [Related]

  • 11. Tuberculosis treatment: dangerous regimens?
    Rieder HL, Arnadottir T, Trébucq A, Enarson DA.
    Int J Tuberc Lung Dis; 2001 Jan 15; 5(1):1-3. PubMed ID: 11263509
    [No Abstract] [Full Text] [Related]

  • 12. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN, Barrera L.
    Medicina (B Aires); 2007 Jan 15; 67(3):231-7. PubMed ID: 17628909
    [Abstract] [Full Text] [Related]

  • 13. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 15; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 14. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec 15; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 15. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS.
    Probl Tuberk Bolezn Legk; 2008 Dec 15; (12):60-3. PubMed ID: 19227326
    [Abstract] [Full Text] [Related]

  • 16. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML, Iuditskiĭ MV, Semenova OV.
    Probl Tuberk Bolezn Legk; 2004 Dec 15; (3):26-8. PubMed ID: 15338896
    [Abstract] [Full Text] [Related]

  • 17. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK, Kim CT, Song SD.
    Int J Tuberc Lung Dis; 1998 Nov 15; 2(11):877-84. PubMed ID: 9848607
    [Abstract] [Full Text] [Related]

  • 18. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A, Rahman M, Raviglione M, Bustreo F.
    Int J Tuberc Lung Dis; 1997 Jun 15; 1(3):231-8. PubMed ID: 9432369
    [Abstract] [Full Text] [Related]

  • 19. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM, Christenson JC, Downs SM.
    Pediatrics; 2009 Mar 15; 123(3):816-22. PubMed ID: 19255008
    [Abstract] [Full Text] [Related]

  • 20. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.
    Int J Tuberc Lung Dis; 2006 Aug 15; 10(8):844-50. PubMed ID: 16898367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.